Find and Pitch Jounalists, Get Your Story Covered

Tags: metformin dementia opioid methadone tobacco

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a Merck deal for an obesity pill, a departing FDA official, and more - 6 days ago STAT+: Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more - about 2 months ago STAT+: Pharmalittle: We’re reading about Zepbound trial results, an Alnylam heart drug, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Roche obesity drug data, fallout from the Menendez verdict, and more - 5 months ago STAT+: Pharmalittle: We’re reading about a Pfizer daily weight loss pill, a Novo Nordisk setback, and more - 6 months ago STAT+: Pharmalittle: We’re reading about Wegovy approved for heart risks, an ALS drug puzzle, and more - 10 months ago STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more - 10 months ago STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more - 11 months ago STAT+: Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages - about 1 year ago STAT+: Pharmalittle: Lilly wins FDA approval for a weight-loss drug; AstraZeneca enters the race for an obesity pill - about 1 year ago STAT+: Pharmalittle: Sarepta Duchenne therapy misses primary endpoint; FDA holds panel for first CRISPR treatment for sickle cell - about 1 year ago STAT+: Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit - about 1 year ago
2	Marissa Plescia MedCity News Reporter at MedCity News. reportingjournalism	Noom Launches Oral Medication Offering for Weight Loss - 12 days ago
3	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots - 16 days ago
4	The Conversation Science Alert Science news. Official account. Australia science news	Ozempic vs Supplements: Dietitian Reveals Truth About GLP-1 Imitations - 27 days ago Type 2 Diabetes Drug Linked to 35% Lower Dementia Risk in Patients - 4 months ago
5	Gillian Booth MedPage Today Singer, social media manager. Philadelphia, Pennsylvania social mediamusic	IG Live December 2: The Weight of Wegovy - 27 days ago
6	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Novel Therapy Reduced Liver Fat, Improved Fibrosis in MASH - about 1 month ago FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes - about 2 months ago Weight-Loss Drug Overdoses; Record Number of Retracted Studies; Yoga and Cadavers - about 1 year ago
7	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Metformin Use Linked to Fewer Asthma Attacks - about 1 month ago
8	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: With new Wegovy data in hand, Novo Nordisk will file for approval in MASH - about 2 months ago STAT+: Lilly’s Zepbound slashed risk of developing diabetes - 4 months ago STAT+: Positive trial results set up obesity drug Wegovy for use against heart failure - 9 months ago STAT+: Liver disease MASH is next target for obesity drugs in development - 10 months ago Eli Lilly gets FDA approval to sell Mounjaro as obesity drug called Zepbound - about 1 year ago
9	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions - about 2 months ago FDA Grants Breakthrough Device Designation for System Maintaining Weight Loss After GLP-1 - 5 months ago Intermittent Fasting and Meal Replacements Improved Short-Term Glycemia - 5 months ago Tirzepatide Shows Improvements in MASH Without Worsening Fibrosis - 6 months ago INHALE-3 Study Data Shows Diabetes Care Is Not “One-Size-Fits-All” - 6 months ago Teva Launches Generic Formulation of Liraglutide in US - 6 months ago FLOW Trial Results Demonstrate Positive Kidney Outcomes With Semaglutide - 10 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - 12 months ago Metformin Cessation Has Been Associated With Increased Dementia Incidence - about 1 year ago
10	Rick Lange, MD, Texas Tech; Elizabeth Tracey MedPage Today Texas Tech University System, advancing higher education and health care. Lubbock, Texas higher educationhealth care	Metformin and Congenital Abnormalities; Deprescribing in Patients With Dementia - about 2 months ago

Journalists covering metformin